Patients
16.0 % of people
People aged 65 and over, Thailand, 2025 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Vidhi Upadhyay
Thailand Biological Age Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.0 Mn | — | — |
| 2025 (base) | $1.2 Mn | +$0.1 Mn | — |
| 2026 (forecast) | $1.3 Mn | +$0.2 Mn | +13.2% |
| 2027 (forecast) | $1.5 Mn | +$0.2 Mn | +28.1% |
| 2028 (forecast) | $1.7 Mn | +$0.2 Mn | +45.1% |
| 2029 (forecast) | $1.9 Mn | +$0.2 Mn | +64.2% |
| 2030 (forecast) | $2.1 Mn | +$0.2 Mn | +85.9% |
| 2031 (forecast) | $2.4 Mn | +$0.3 Mn | +110.4% |
| 2032 (forecast) | $2.7 Mn | +$0.3 Mn | +138.2% |
| 2033 (forecast) | $3.1 Mn | +$0.4 Mn | +169.6% |
| 2034 (forecast) | $3.5 Mn | +$0.4 Mn | +205.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $3.5 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 13.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, channel and end user (see all) |
| Key players | TruDiagnostic, Tally Health, InsideTracker, GlycanAge, Elysium Health (see all) |
| Regulator in Thailand | Thai FDASource: Thai Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Biological age tests estimate how fast a person is ageing using DNA methylation, blood markers or other data, rather than their age in years.
Key segments of the biological Age Testing market include test (Epigenetic Clocks, Blood Biomarker Panels and Telomere Tests) and channel (Direct-to-Consumer, Clinics and Research).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the biological Age Testing market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the biological Age Testing market.
The biological Age Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices are regulated by the Thai Food and Drug Administration (Thai FDA), by risk class.[1] The Universal Coverage Scheme, run by the National Health Security Office (NHSO), covers people outside the social security and civil servant schemes.[2] People aged 65 and over: 16.0% of people in 2025, the latest WHO figure for Thailand.[3]
[1] Thai Food and Drug Administration. Checked 14 Nov 2026.
[2] National Health Security Office. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biological Age Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Thailand.
What doctors and scientists are doing in Biological Age Testing right now, from free public sources.
16.0 % of people
People aged 65 and over, Thailand, 2025 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
From our blog
Thailand · 1 shared keyword
Thailand · 1 shared keyword
Thailand · 1 shared keyword
Thailand · 1 shared keyword
Thailand · 1 shared keyword
Thailand · 1 shared keyword
Pharmaceuticals · Thailand
Healthcare Services · Thailand
Digital Health · Thailand
Digital Health · Thailand
Healthcare Services · Thailand
Pharmaceuticals · Thailand